Transgene Biotek has informed that, pursuant to SEBI (Prohibition of Insider trading) Regulation, 2015 read with the Company's Insider Trading Policy including Code of Conduct for regulating, monitoring and reporting of trading by designated persons and their immediate relatives, the Trading Window for dealing in the shares of the Company is closed with effect from July 1, 2024 till 48 hours after the declaration of un-audited financial results of the Company for the first quarter ended June 30, 2024. The date of Board Meeting for the consideration of un-audited financial results of the Company for the quarter ended June 30, 2024 shall be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
